Medifocus Announces progress Conference Call Pertaining to I.D.E. Application to the FDA to Initiate Pivotal Phase-3 trials for Microwave Breast Cancer Treatments on Tuesday 3/9/2010 at 10 am EST

VANCOUVER--(BUSINESS WIRE)--Medifocus, Inc. (OTC:MDFZF.PK and TSXV:MFS) is pleased to announce that Dr. Augustine Cheung, CEO of Medifocus, Inc, will be providing updates to the investment public on an interactive conference call Tuesday 3/9/2010 at 10 am EST. The call will reveal the status of the FDA trials for its microwave breast cancer treatment technologies along with progress reports on all other important company matters. This forum will allow for questions and answers following Dr. Cheung's updates. All of the investment public are invited to attend and participate in the conference call.
MORE ON THIS TOPIC